Rettsyndrome.org: Translational Research LOI

HeART: designed to promote the development and testing of therapeutics to treat and reverse Rett syndrome (RTT).  The goal of this award mechanism is to provide seed funding for early stage drug discovery and development efforts. Funding: $150,000 for 2 years

ANGEL: focused on pre-clinical drug discovery and development or clinical testing of therapeutic candidates. The goal is to provide larger, multi-year awards with a strong emphasis placed on the later stages of translational research. Funding: $600,000 for 2 years

(Please contact the research authority if planning to submit: non- profit)

https://www.rettsyndrome.org/research/funding-opportunities